LncRNA ABHD11‐AS1 is overexpressed and associated with tumour size and stage in gastric cancer and may have potential as a screening biomarker for gastric cancer.6 ABHD11‐AS1 is also overexpressed in ovarian cancer and bladder cancer,7, 8 and can promote proliferation and invasion and inhibit apoptosis in ovarian cancer and bladder cancer cells, thus may represent a potential target for bladder cancer. Here, ABHD11 is linked to neoplasm.